ARAY
Price:
$1.93
Market Cap:
$194.09M
Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy System, including the Radixact System, which allows for integrated rad...[Read more]
Industry
Medical - Specialties
IPO Date
2007-02-08
Stock Exchange
NASDAQ
Ticker
ARAY
According to Accuray Incorporated’s latest financial reports and current stock price. The company's current ROE is -36.93%. This represents a change of 300.78% compared to the average of -9.21% of the last 4 quarters.
The mean historical ROE of Accuray Incorporated over the last ten years is -30.64%. The current -36.93% ROE has changed 20.54% with respect to the historical average. Over the past ten years (40 quarters), ARAY's ROE was at its highest in in the December 2019 quarter at 19.13%. The ROE was at its lowest in in the September 2019 quarter at -22.83%.
Average
-30.64%
Median
-33.71%
Minimum
-63.57%
Maximum
6.10%
Discovering the peaks and valleys of Accuray Incorporated ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 99.37%
Maximum Annual ROE = 6.10%
Minimum Annual Increase = -250.40%
Minimum Annual ROE = -63.57%
Year | ROE | Change |
---|---|---|
2024 | -34.48% | 99.37% |
2023 | -17.29% | 72.04% |
2022 | -10.05% | 9.66% |
2021 | -9.17% | -250.40% |
2020 | 6.10% | -118.50% |
2019 | -32.94% | -32.96% |
2018 | -49.14% | -22.69% |
2017 | -63.57% | 48.70% |
2016 | -42.75% | -19.43% |
2015 | -53.06% | 47.51% |
The current ROE of Accuray Incorporated (ARAY) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-20.61%
5-year avg
-12.98%
10-year avg
-30.64%
Accuray Incorporated’s ROE is greater than Surmodics, Inc. (-9.56%), greater than AxoGen, Inc. (-14.91%), greater than Bioventus Inc. (-24.50%), less than Cutera, Inc. (63.25%), less than NuVasive, Inc. (4.86%), greater than Paragon 28, Inc. (-38.77%), greater than Orthofix Medical Inc. (-21.25%), greater than SI-BONE, Inc. (-22.51%), less than Avanos Medical, Inc. (1.28%), less than Aziyo Biologics, Inc. (78.94%), greater than Apyx Medical Corporation (-156.40%), greater than INVO Bioscience, Inc. (-1073.76%), less than Artivion, Inc. (-0.29%), greater than Anika Therapeutics, Inc. (-48.10%), greater than Sight Sciences, Inc. (-47.28%), greater than Cytosorbents Corporation (-13069.04%), greater than NeuroPace, Inc. (-205.41%), greater than ClearPoint Neuro, Inc. (-62.10%), greater than TELA Bio, Inc. (-556.18%), greater than OrthoPediatrics Corp. (-7.64%),
Company | ROE | Market cap |
---|---|---|
-9.56% | $561.12M | |
-14.91% | $587.07M | |
-24.50% | $765.46M | |
63.25% | $6.39M | |
4.86% | $2.08B | |
-38.77% | $838.76M | |
-21.25% | $722.63M | |
-22.51% | $526.74M | |
1.28% | $854.80M | |
78.94% | $24.21M | |
-156.40% | $54.40M | |
-1073.76% | $3.25M | |
-0.29% | $1.19B | |
-48.10% | $248.54M | |
-47.28% | $203.53M | |
-13069.04% | $50.31M | |
-205.41% | $289.53M | |
-62.10% | $326.46M | |
-556.18% | $118.56M | |
-7.64% | $637.85M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Accuray Incorporated using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Accuray Incorporated or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Accuray Incorporated's ROE?
How is the ROE calculated for Accuray Incorporated (ARAY)?
What is the highest ROE for Accuray Incorporated (ARAY)?
What is the 3-year average ROE for Accuray Incorporated (ARAY)?
What is the 5-year average ROE for Accuray Incorporated (ARAY)?
How does the current ROE for Accuray Incorporated (ARAY) compare to its historical average?